W2O acquires med comms agency Arcus MedicaHealthcare marketing communications agency W2O has acquired Philadelphia’s Arcus Medica to boost its scientific and med comms offering. Share XW2O acquires med comms agency Arcus Medicahttps://pharmaphorum.com/news/w2o-med-comms-agency-arcus-medica/
Debt-laden Takeda to sell OTC drugs in Middle East and Africa for $200mTakeda is to sell off a portfolio of over-the-counter and prescription drugs in the Near East, Middle East, Share XDebt-laden Takeda to sell OTC drugs in Middle East and Africa for $200mhttps://pharmaphorum.com/news/takeda-to-sell-otc-drugs-in-middle-east-and-africa-for-200m/
Pfizer’s Xeljanz follow-up abrocitinib gathers momentumPfizer has reported new data with abrocitinib, a follow-up to its JAK inhibitor Xeljanz, which is facing increased Share XPfizer’s Xeljanz follow-up abrocitinib gathers momentumhttps://pharmaphorum.com/news/pfizers-xeljanz-follow-up-abrocitinib-gathers-momentum/
Sanofi opens digital biologics manufacturing siteSanofi has opened a manufacturing facility in the US, one of the world’s first facilities using digital continuous Share XSanofi opens digital biologics manufacturing sitehttps://pharmaphorum.com/news/sanofi-opens-digital-biologics-manufacturing-site/
Reata rockets on data for Nrf2 drug reacquired from AbbVieReata Pharma has reported positive clinical results with one of its Nrf2 activators for mitochondrial diseases, just days Share XReata rockets on data for Nrf2 drug reacquired from AbbViehttps://pharmaphorum.com/news/reata-rockets-on-data-for-nrf2-drug-reacquired-from-abbvie/
FDA approves Bayer/Janssen’s Xarelto in new blood clot prevention useBayer and Janssen’s novel oral anticoagulant (NOAC) Xarelto has a new string to its bow after the FDA Share XFDA approves Bayer/Janssen’s Xarelto in new blood clot prevention usehttps://pharmaphorum.com/news/fda-approves-bayer-janssens-xarelto-in-new-blood-clot-prevention-use/
Guido Körfer and Marc Henschel join McCann Health GermanyPictured from left: Guido Körfer, Effie Baoutis and Marc Henschel McCann Health Germany has made two key appointments Share XGuido Körfer and Marc Henschel join McCann Health Germanyhttps://pharmaphorum.com/news/korfer-henschel-mccann-health-germany/
Roche backs Rituxan with further data in rare skin disease PVRoche’s Rituxan (rituximab) has been on the market for years as a blood cancer drug, and is finally Share XRoche backs Rituxan with further data in rare skin disease PVhttps://pharmaphorum.com/news/roche-backs-rituxan-with-further-data-in-rare-skin-disease-pv/
NHS-backed mental health site launches in EnglandPublic Health England and the NHS have launched an online service helping people to take simple steps to Share XNHS-backed mental health site launches in Englandhttps://pharmaphorum.com/news/nhs-backed-mental-health-site-launches-in-england/
